Bradicardia fetalestudio multicéntrico retrospectivo en 9 hospitales españoles

Referencias bibliográficas

• D.B. Southall, J. Richards, R.S. Hardwick, E.A. Shinebourne, G.L. Gibbens, and H. Thelwall-Jones Prospective study of fetal heart rate and rhythm patterns Arch Dis Child 55 1980 506 511
• E.T. Jaeggi, and M.K. Friedberg Diagnosis and management of fetal bradyarrhytmias PACE 31 2008 S50 S53
• E.T. Jaeggi, R.M. Hamilton, E.D. Silverman, and L.K. Hornberger Outcome of children with fetal, neonatal or childhood diagnosis of isolated complete heart block. A single institution's experience of 30 years J Am Coll Cardiol 39 2002 130e7
• J.P. Buyon, R. Hiebert, J. Copel, J. Craft, D. Friedman, and M. Katholi Autoinmune-associated congenital heart block: Demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry J Am Coll Cardiol 31 1998 1658 1666
• K.G. Schmidt, H.E. Ulmer, N.H. Silverman, C.S. Kleinman, and J.A. Copel Perinatal outcome of fetal complete atrioventricular block: A multicenter experience J Am Coll Cardiol 17 1991 1360 136061366
• J.I. Pike, M.T. Donofrio, and Berul Cl Ineffective therapy, underpowered studies, or merely too little, too late? Risk factors and impact of maternal corticosteroid treatment on outcome in antibody-associated fetal heart block Circulation 124 2011 1905 1907
• S.Y. Ho, E. Esscher, R.H. Anderson, and M. Michaelsson Anatomy of congenital complete heart block and relation to maternal anti-Ro antibodies Am J Cardiol 58 1986 291 294
• J.P. Buyon, N.Y. Kim, J.A. Copel, and D. Friedman AntiRo/SSA antibodies and congenital heart block: Necessary but not sufficient Arthritis Reum 44 2001 1832 1835
• L.E. Nield, E.D. Silverman, G.P. Taylor, J.F. Samllhorn, J.B. Mullen, and N.H. Silverman Maternal anti-Ro and anti-La antibody-associated endocardial fibroelastosis Circulation 105 2002 843 848
• J.P. Buyon, S.H. Swersky, H.E. Fox, F.Z. Bierman, and R.J. Winchester Intrauterine therapy for presumptive fetal myocarditis with acquired heart block due to systemic lupus erythemathosus. Experience in a mother with a predominance of SS-B (La) antibodies Arthritis Rheum 30 1987 44e9
• F.Z. Bierman, L. Baxi, I. Jaffe, and J. Driscoll Fetal hydrops and congenital complete heart block: Response to maternal steroid therapy J Pediatr 112 1988 646 648
• R. Kaaja, H. Julkunen, P. Ammala, A.M. Teppo, and P. Kurki Congenital heart block: Successful prophylactic treatment with intravenous gamma globulin and corticosteroid therapy Am J Obstet Gynecol 165 1991 1333 1334
• E.T. Jaeggi, J.C. Fouron, E.D. Silverman, G. Ryan, J. Smallhorn, and L.K. Hornberger Transplacental treatment improves the outcome of prenatally diagnosed complete atrioventricular block without structural heart disease Circulation 110 2004 1542 1548
• L.M. Lopes, G.M. Penha Tavares, A.P. Damiano, M.A. Borges Lopes, V. Demarchi Aiello, and R. Schultz Perinatal outcome of fetal atrioventricular block one-hundred-sixteen cases from a single institution Circulation 118 2008 1268 1275
• H. Eliasson, S.E. Sonesson, G. Sharland, F. Granath, J.M. Simpson, J.S. Carvalho for the Fetal Working Group of the European Association of Pediatric Cardiology Isolated atrioventricular block in the fetus. A retrospective, multinational, multicenter study of 175 patients Circulation 124 2011 1919 1926
• G.A. Macones, G.D. Hankins, C.Y. Spong, J. Hauth, and T. Moore The 2008 National Institute of Child Health and Human Development workshop on electronic fetal monitoring: Update on definitions, interpretation, and research guidelines Obstet Gynecol 112 2008 661 666
• J.S. Glickstein, J. Buyon, and D. Friedman Pulsed doppler echocardiographic assessment of the fetal PR interval Am J Cardiol 86 2000 236 238
• J.F. Strasburger, B. Cheulkar, and H.J. Wichman Perinatal arrhythmias: Diagnosis and management Clin Perinatol 34 2007 627 652
• J.M. Simpson, R.W. Yates, and J.K. Sharland Irregular heart rhythm in the fetus, not always benign Cardiol Young 6 1996 28 31
• Y. Maeno, N. Rikitake, O. Toyoda, Y. Kiyomatsu, T. Miyake, and W. Himeno Prenatal diagnosis of sustained bradycardia with 1:1 atrioventricular conduction Ultrasound Obstet Gynecol 21 2003 234 238
• E. Beinder, T. Grancay, T. Menéndez, H. Siger, and M. Hofbeck Fetal synus bradicardia and the long QT syndrome Am J Obstet Gynecol 185 2001 743 747
• A.E. Baruteau, and J.M. Schlein Antenatal presentation of congenital long QT syndrome: A prenatal diagnosis not to be missed Pediatr Cardiol 29 2008 1131 1132
• S. Ozkutlu, L. Onderoglu, T. Karagoz, A. Celiker, and U.M. Sahiner Isolated no compactation of left ventricular myocardium with fetal sustained bradycardia due to sick sinus syndrome Turk J Pediatr 48 2006 383 386
• B.F. Cuneo, J.F. Strasburger, A. Nikssch, M. Ovadia, and R.T. Wakai An expanded phenotype of maternal SSA/SSB antibody associated fetal cardiac disease J Matern Fetal Neonatal Med 22 2009 233 238
• E.T. Jaeggi, L.K. Hornberger, J.F. Smallhorn, and J.C. Fouron Prenatal diagnosis of complete atrioventricular block associated with structural heart disease: Combined experience of two tertiary care centers and review of the literature Ultrasound Obstet Gynecol 26 2005 16 21
• A.C. Glatz, J.W.G. Gaynor, L.A. Rhodes, J. Rychik, R.E. Tanel, and V.L. Vetter Outcome of high-risk neonates with congenital complete heart block paced in the first 24 hours after birth J Thorac Cardiovasc Surg 136 2008 767 773
• A.A. Baschat, U. Gembruch, G. Knopfle, and M. Hansmann First trimester fetal heart block: A marker for cardiac anomaly Ultrasound Obstet Gynecol 14 1999 311 314
• A.E. Baruteau, S.S. Fouchard, A.A. Behaghel, P.P. Mabo, E.E. Villain, and J.B. Thambo Characteristics and long-term outcome of non-immune isolated atrioventricular block diagnosed in utero or early childhood: A multicentre study Eur Heart J 33 2012 622 629
• J.P. Buyon, R.M. Clancy, and D.M. Friedman Autoinmune associated congenital heart block: Integration of clinical and research clues in the management of the maternal/foetal dyad at risk J Intern Med 265 2009 653 662
• S. Saleeb, J. Copel, D. Friedman, and J.P. Buyon Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody associated congenital heart block Arthritis Rheum 42 1999 2335 2345
• V. Fesslova, G. Vignati, A. Brucato, M. de Sanctis, G. Butera, and M.P. Bison The impact of treatment of the fetus by maternal therapy on the fetal and postnatal outcomes for fetuses diagnosed with isolated complete atrioventricular block Cardiol Young 19 2009 282 290
• A.J. Rein, D. Mevorach, Z. Perles, S. Gavri, M. Nasjari, and A. Nir Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies Circulation 119 2008 1867 1872
• E.T. Jaeggi, E.D. Silverman, C. Laskin, J. Kingdom, F. Gloding, and R. Weber Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA anti-La/SSB antibodies din not predict progressive heart block J Am Coll Cardiol 57 2011 1487 1492
• D.M. Friedman, M.J. Kim, J.A. Copel, C. Llanos, C. Davis, and J.P. Buyon Prospective evaluation of fetuses with autoimmune associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study Am J Cardiol 103 2009 1102 1106
• D. Askanase, D.M. Friedman, J. Copel, M.R. Dische, A. Dubin, and T.J. Stark Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies Lupus 11 2002 145 151
• NIH Consensus Development Panel Antenatal corticosteroids revisited: Repeat courses Obstet Gynecol 98 2001 144 150
• N. Costedoat-Chalumeau, Z. Amoura, D. Le Thi Hong, B. Wechsler, D. Vauthier, and P. Ghillani Questions about dexamethasone use for the prevention of anti-SSA related congenital heart block Ann Rheum Dis 62 2003 1010 1012
• J.M.P.J. Breuer, G.H.A. Visser, A.A. Kruize, P. Stoutenbeek, and J. Meijboom Treatment of fetal heart block with maternal steroid therapy: Case report and review of the literature Ultrasound Obstet Gyncecol 24 2004 467 472
• E. Jaeggi, C. Laskin, R. Hamilton, J. Kingdom, and E. Silverman The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erytemathosus J Am Coll Cardiol 55 2010 2778 2784
• C. Medrano-López, and J.C. Fouron Cardiología fetal. La frontera de la medicina cardiovascular Rev Esp Cardiol 65 2012 700 704